CMS boosts home health pay—but strings, tech, and tighter scrutiny shape the new normal

After several years of payment reductions, CMS is proposing a 2.4% net increase in Medicare home health payments for 2027, combining a 2.1% base update with a temporary 3.0% negative adjustment to recoup prior overpayments. This adjustment, valued at approximately $420 million compared to 2026, signals a cautious yet positive shift in funding that home health agencies will need to strategically navigate amid evolving regulatory demands.

Alongside payment changes, CMS is aggressively enhancing program integrity through measures like retroactive revocations tied to the onset of noncompliance, geographic saturation triggers that limit provider density, and expanded denial criteria including past misdemeanor sexual assault or financial misconduct within the last decade. These reforms extend beyond home health, targeting high-risk Medicare segments such as hospice and durable medical equipment, thereby broadening the scope and impact of provider enrollment oversight.

By embedding these stringent enrollment and compliance rules within the home health payment rule, CMS is effectively converting enforcement into a sustained market opportunity for compliance technology and services. Tools for provider screening, ownership-graph analysis, ongoing monitoring, and audit response are poised to see increased demand, as agencies and stakeholders seek to mitigate risks and adapt to the heightened regulatory environment that CMS estimates will save roughly $82 million annually by curbing fraud and improper payments.

Amid the CMS six-month enrollment moratorium, providers like Andwell Health Partners are doubling down on organic growth strategies to navigate regulatory constraints. CEO Ken Albert emphasizes efforts to increase census within existing service areas, strengthen referral relationships, and expand clinical capacity by enhancing workforce availability. This focus on optimizing current operations reflects a pragmatic approach to sustaining growth when new Medicare home health enrollments are temporarily frozen.

Simultaneously, joint ventures are emerging as a favored alternative to traditional mergers and acquisitions during the moratorium, offering providers a pathway to expand without triggering enrollment restrictions. While M&A remains possible, the regulatory barriers make joint ventures more attractive for strategic growth, enabling operators to collaborate and share resources effectively. This shift underscores a nuanced adaptation where providers leverage partnerships to circumvent moratorium limitations and maintain momentum in a challenging market.

AI-driven automation is revolutionizing operational efficiency and cost management within Medicare Advantage plans, as demonstrated by Alignment Healthcare's leap in claims auto-adjudication from under 15% to over 60% within a year. This technological advancement contributed to a 60 basis point reduction in adjusted SG&A expenses and a 90 basis point increase in adjusted EBITDA margin by Q1 2026, underscoring how innovation directly enhances financial performance. Furthermore, Alignment’s strategic focus on enrolling higher-acuity members, particularly through its Chronic Condition Special Needs Plan, aligns with broader industry efforts to reduce avoidable hospitalizations and emergency visits, thereby improving quality ratings and member retention—critical factors that have kept 100% of its members in plans rated 4 stars or higher for 2026 and sustained a nine-year streak of high ratings in California.

The home health care sector is navigating a complex regulatory and market landscape shaped by CMS’s 2026 Medicare enrollment moratorium and a proposed 2.4% payment increase for 2027, prompting providers to recalibrate growth strategies amid uncertainty. This environment has elevated joint ventures as a preferred expansion model over traditional mergers and acquisitions, enabling providers to adapt more flexibly to new program integrity measures and enrollment restrictions. Meanwhile, hospital-at-home programs are experiencing waning confidence, signaling a potential slowdown in what was once a rapidly expanding segment of home-based care, thereby forcing companies to rethink their competitive positioning and service delivery models.

Home care providers in 2026 face mounting pressures from Medicaid policy shifts, including proposed 80-hour work requirements and intensified fraud scrutiny, which are reshaping operational priorities and competitive dynamics. Companies like Chicago-based Avid Health at Home exemplify the sector’s response by leveraging sustained acquisition activity—recently completing its eighth acquisition with Tech Medical Home Care Services—to fuel growth and operational transformation. This dealmaking momentum is often paired with strategic investments in technology adoption, reflecting a broader industry trend where innovation is not just a differentiator but a necessity for scaling and competing effectively in an evolving market.